Skip to Content

Notice

Guideline for the Clinical Evaluation of Analgesic Drugs; Withdrawal of Guidance

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice; withdrawal.

SUMMARY:

The Food and Drug Administration (FDA) is announcing the withdrawal of a guidance entitled “Guideline for the Clinical Evaluation of Analgesic Drugs,” which was issued on December 1, 1992. The guidance is outdated and no longer reflects FDA's current thinking on development of analgesic drugs. FDA is revising the guidance and will issue a draft for public comment in the future.

DATES:

Comments on agency guidances are welcome at any time.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Barbara J. Gould, Center for Drug Evaluation and Research (HFD-550), Food and Drug Administration, 5600 Rockville Pike, Rockville, MD 20850, 301-827-2504.

End Further Info Start Signature

Dated: July 28, 2003.

Jeffrey Shuren,

Assistant Commissioner for Policy.

End Signature End Preamble

[FR Doc. 03-19802 Filed 8-4-03; 8:45 am]

BILLING CODE 4160-01-S